Please login to the form below

Not currently logged in
Email:
Password:

Glenmark

This page shows the latest Glenmark news and features for those working in and with pharma, biotech and healthcare.

Gilead and ViiV among winners at PM Society Digital Awards

Gilead and ViiV among winners at PM Society Digital Awards

Allergan, Glenmark, Grunenthal, Merck Serono, MSD and Novartis and all won Gold as well.

Latest news

  • EMA suspends generic drugs on data integrity concerns EMA suspends generic drugs on data integrity concerns

    Included in the lengthy list of medicines affected by the suspension are products sold by Sandoz, Teva, Mylan, Sanofi, Biogaran Ratiopharm, Glenmark and Accord Healthcare, amongst many other firms, and most

  • Indian court blocks generic of Merck's Januvia Indian court blocks generic of Merck's Januvia

    India's Supreme Court has prevented Glenmark Pharmaceuticals from making and selling a generic of Merck &Co's diabetes blockbuster Januvia. ... Glenmark was ordered to pay part of Merck's legal fees but was excused compensation.

  • UCB files Vimpat patent claims against 15 companies UCB files Vimpat patent claims against 15 companies

    UCB files Vimpat patent claims against 15 companies. Aurobindo, Glenmark, Mylan, Ranbaxy and Sandoz all face legal challenge over generic versions of UCB's epilepsy drug. ... These other firms include major players in the generics market, such as Glenmark

  • Merck wins injunction against Januvia generics in India Merck wins injunction against Januvia generics in India

    The patent infringement case against Glenmark centred on the salt form of sitagliptin used in Zita and Zita Met. ... why the courts have blocked Aprica's products whilst letting Glenmark's remain on the market.

  • Merck & Co fails to block generic Januvia in India Merck & Co fails to block generic Januvia in India

    Merck &Co fails to block generic Januvia in India. Court says Glenmark can sell cheap copy of diabetes drug. ... of its price in the US – while Glenmark's versions are sold at a 20-30 per cent discount.

More from news
Approximately 4 fully matching, plus 22 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

EU
Innovation in merger control and the impact on the pharmaceutical sector
Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think
Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...
Peoples Award
Quality in Care Diabetes 2018: the best in innovative diabetes care
Awards highlight new evidence-based approaches to improving care...

Infographics